XLIMUS is considered as the ultimate coronary DES stent system to treat complex coronary artery disease by reaching and crossing the most challenging lesions.
XLIMUS. Designed for the
most challenging lesions.
Optimal Deliverability
Optimal Crossability
Highest Stenting Success !
It provides fully biodegradable drug elution.
No stent flaring. No tissue prolapse. Clinically effective.
The unique XLIMUS 6-8-10 stent cell design.
Ensures even vessel wall coverage. Any different artery lesion diameter ranging from 2.25 up to 5.00mm is stented evenly.
Homogenous, clinically effective drug delivery optimizes the anti-proliferative protection of the stented lesion segment.
No stent strut flaring. No open gaps.
The technically high standard of 6-8-10 intermediate and closed-cell stent architecture covers all vessel diameters evenly. XLIMUS quality ensures the best possible intracoronary stenting stability and minimizes stenting trauma and restenosis. Extraordinary homogenous vessel wall scaffolding.
XLIMUS assists the cardiologist
with an optimal, unsurpassed tracking performance. It has an innovative Hydrophilic-coated shaft and an extra-low tip profile to access the most tortuous lesions. The ultra-low lesion crossing profile measures only 0.90 mm. The novel XLIMUS Sirolimus-eluting coronary stent system protects the stented lesion segment through extraordinary homogeneous vessel wall scaffolding which minimizes the risk of tissue prolapse and optimizes Sirolimus drug distribution.